Carolina Soares, Lucas Uglione Da Ros, Luiza Santos Machado, Andreia Rocha, Gabriela Lazzarotto, Giovanna Carello-Collar, Marco A De Bastiani, João Pedro Ferrari-Souza, Firoza Z Lussier, Diogo O Souza, Pedro Rosa-Neto, Tharick A Pascoal, Bruna Bellaver, Eduardo R Zimmer
Glutamatergic neurotransmission system dysregulation may play an important role in the pathophysiology of Alzheimer's disease (AD). However, reported results on glutamatergic components across brain regions are contradictory. Here, we conducted a systematic review with meta-analysis to examine whether there are consistent glutamatergic abnormalities in the human AD brain. We searched PubMed and Web of Science (database origin-October 2023) reports evaluating glutamate, glutamine, glutaminase, glutamine synthetase, glutamate reuptake, aspartate, excitatory amino acid transporters, vesicular glutamate transporters, glycine, D-serine, metabotropic and ionotropic glutamate receptors in the AD human brain (PROSPERO #CDRD42022299518)...
February 16, 2024: Molecular Psychiatry